{"id":4830,"date":"2022-11-02T14:48:35","date_gmt":"2022-11-02T14:48:35","guid":{"rendered":"https:\/\/cancer-expert.com\/about-the-person\/"},"modified":"2026-01-21T11:19:25","modified_gmt":"2026-01-21T11:19:25","slug":"about-the-person","status":"publish","type":"page","link":"https:\/\/cancer-expert.com\/en\/about-the-person\/","title":{"rendered":"About the person"},"content":{"rendered":"\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n
\n
\n
\n
\n
\n
\n

Key areas of research<\/span> <\/h2>\n

Cancer Expert Prof. Dr. Richard Greil is one of the most cited physicians in the world, which underlines his important role in the scientific community and his contribution to medical research. His numerous publications in prestigious journals have been recognized worldwide and are frequently cited by other researchers and physicians. This demonstrates not only the quality and relevance of the Cancer Expert’s work, but also the impact of his research on the field of oncology and beyond. <\/p>\n

In particular, his work on leukemias, lymphomas, and solid tumors, as well as his contributions to the development of new therapies and precision medicine, have contributed significantly to making him one of the most cited cancer experts. Prof. Dr. Greil’s research findings have provided new insights that have improved clinical practice and advanced innovative treatment methods. <\/p>\n

The high citation frequency of his work also reflects the importance of his research to the scientific community and shows that his findings are valued and used by colleagues worldwide to advance oncology research and treatment.<\/p>\n

More about the Salzburg Cancer Research Institute<\/a><\/p>\n\n <\/div>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n

\n
\n
\n
\n
\n
\n

Awards<\/span> <\/h2>\n

The Cancer Expert has been awarded the Grand Cross of Merit in Silver for services to the Republic of Austria.<\/span><\/p>\n\n <\/div>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n

\n
\n
\n
\n
\n
\n

Career \/ Curriculum<\/span> <\/h2>\n

1983<\/strong>
\nMedical studies at the Leopold Franzens University of Innsbruck<\/p>\n

Doctorate awarded sub auspiciis praesidentis rei publicae Austriae<\/p>\n

1990<\/strong>
\nBoard Certification for Internal Medicine<\/p>\n

1992<\/strong>
\nHabilitation in internal medicine at the Leopold Franzens University of Innsbruck<\/p>\n

1995<\/strong>
\nBoard Certification for Hematology and Medical Oncology<\/p>\n

1997<\/strong>
\nAppointed Associate Professor at the Leopold Franzens University of Innsbruck <\/p>\n

Deputy Director of the Division of Hematology and Medical Oncology at the Leopold Franzens University of Innsbruck<\/p>\n

1998<\/strong>
\nFounding member of the Tyrolean Cancer Research Institute<\/p>\n

2001-2004<\/strong>
\nScientific Director of the Tyrolean Cancer Research Institute<\/p>\n

2004<\/strong>
\nHead of the III Medical University Clinic in Salzburg, comprising Hematology, Medical Oncology, Hemostasis, Infectious Diseases, and Rheumatology; Oncology Center at the Paracelsus Medical Private University Salzburg<\/p>\n

Founder and Managing Director of the Center for Clinical Cancer and Immunology Trials (CCCIT) at the III Medical University Clinic (now Salzburg Cancer Research Institute \u2013 CCCIT GmbH)<\/p>\n

2005<\/strong>
\nFounder and Managing Director of the Laboratory for Immunological and Molecular Cancer Research of the Salzburg Cancer research Institute (SCRI-LIMCR Gmbh)
And Founder of the Laboratory for Molecular Cytology at the IIIrd Medical University Salzburg<\/p>\n

Additional Board Certification in Rheumatology<\/p>\n

2004 ff<\/strong>
\nPresident and Scientific Director of the “Arbeitsgemeinschaft Medikament\u00f6se Tumortherapie (AGMT)-GesmbH”<\/em><\/p>\n

Vice President of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)<\/p>\n

2007<\/strong>
\nAdditional Board Certification in Infectious Diseases and Tropical Medicine<\/p>\n

Establishment and leadership of the Stem Cell Laboratory at the IIIrd Medical University Clinic Salzburg<\/p>\n

2012-2017<\/strong>
\nVice President of the Austrian Society for Hematology and Oncology (\u00d6GHO)<\/p>\n

2013<\/strong>
\nFounder and scientific director of the Salzburg Cancer Research Institute GmbH<\/em><\/p>\n

2013 ff<\/strong>
\nFounder and Director of the Cancer Cluster Salzburg (an interinstitutional collaboration between SCRI-LIMCR GmbH, SCRI-CCCIT GmbH, the Salzburg University Hospitals (SALK), and the Paris Lodron University of Salzburg)<\/p>\n

2013-14<\/strong>
\nMedical Director of the Oncology Rehabilitation Center in St. Veit im Pongau<\/p>\n

2017<\/strong>
\nHonorary Professor at the Faculty of Natural Sciences, Paris Lodron University of Salzburg<\/p>\n

2019<\/strong>
\nHead of the Working Group for Research and Science within the PREVENIRE project for developing the White Paper on Austria\u2019s Healthcare System 2030<\/p>\n

2020\/March<\/strong>
\nMedical Director of the COVID-19 Crisis Team of the Salzburg University Hospitals (SALK) until 22 April 2020<\/p>\n

Medical Director of the COVID-19 Crisis Team of the Province of Salzburg until 22 April 2020<\/p>\n

Recipient of the International Grand Prize for Science and Research of the City of Salzburg<\/p>\n

Founder and Scientific Managing Director of the Austrian Cancer Research and Development GmbH<\/p>\n

2021\/June
\n<\/strong>Awarded the Grand Silver Medal of Merit of the Republic of Austria for services to the nation<\/p>\n

2024
\n<\/strong>Founding of the IIT (Institute for Individualized Immunotherapy Research and Development) Gmbh<\/p>\n

Looking back on my career (press clipping)<\/a><\/p>\n\n <\/div>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n\n \n \n \n

\n
\n
\n \n
\n \n \n\n \n \n \n \n \n \n \n \"Prof.\n <\/picture>\n \n <\/figure>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n
\n
\n
\n
\n
\n
\n

My management functions<\/span> <\/h2>\n

Head of the Salzburg Cancer Research Institute (SCRI-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR); SCRI Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT)
\nFind out more<\/a><\/p>\n

Head of the Cancer Cluster Salzburg
\nFind out more<\/a><\/p>\n

Head of the Austrian Group for Medical Tumor Therapy (AGMT)
\nFind out more<\/a><\/p>\n

2004 to 2024 Head of the III MedicalDepartment with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg<\/p>\n

2004 to 2024 Head of Oncologic Center, Private Medical University Hospital Salzburg<\/p>\n

 <\/p>\n\n <\/div>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n

\n
\n \n \n
\n \n
\n \n \n \n \n \n \n \"A\n <\/picture>\n <\/figure>\n <\/div>\n \n
\n \n \n \n \n \n \n \n \n \"A\n <\/picture>\n <\/figure>\n <\/div>\n \n
\n
\n
\n

Stays abroad<\/span> <\/h2>\n